Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Non-Current Assets (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Other Non-Current Assets for 7 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 26.09% to $1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2025, up 26.09% year-over-year, with the annual reading at $1.0 million for FY2025, 26.09% up from the prior year.
  • Other Non-Current Assets hit $1.0 million in Q4 2025 for IDEAYA Biosciences, up from $805000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.0 million in Q4 2025 to a low of $99000.0 in Q4 2022.
  • Historically, Other Non-Current Assets has averaged $498350.0 across 5 years, with a median of $722000.0 in 2023.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 664.65% in 2023 and later fell 11.64% in 2025.
  • Year by year, Other Non-Current Assets stood at $106000.0 in 2021, then dropped by 6.6% to $99000.0 in 2022, then surged by 664.65% to $757000.0 in 2023, then rose by 6.34% to $805000.0 in 2024, then rose by 26.09% to $1.0 million in 2025.
  • Business Quant data shows Other Non-Current Assets for IDYA at $1.0 million in Q4 2025, $805000.0 in Q3 2025, and $805000.0 in Q2 2025.